Zimmer Biomet’s revenue in the second quarter of 2025 increased with a 7% increase year over year, according to financial results posted Aug. 7.
Five things to know:
1. Quarterly sales reached $2.07 billion, and Zimmer Biomet’s net earnings were $152.8 million.
2. Knee sales increased 3.1% with $826 million, and hip sales were up 5.8% with $536.1 million.
3. Sports medicine, extremities, trauma, craniomaxillofacial and thoracic sales rose 17.3% year over year to $550.6 million.
4. U.S. sales increased 6.1% year over year with $1.8 billion. International sales were just under $1 billion.
5. Zimmer Biomet projects its full-year revenue to increase 6.7% to 7.7% compared to 2024.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
